Nearly $263.4m in additional funding compared to previous fiscal year's total allocated to FDA in the House appropriations bill. More than 70% of increase, about $185.3m, would be in non-user fees or budget authority and $78.1m in would come from user fee revenue. Bill identifies an additional user fee program for agency in the event Congress passes legislation to overhaul FDA's OTC drug monograph process.
The US Food and Drug Administration's fiscal year 2020 budget would grow significantly under House appropriators' plan, but the rate of increase dropped substantially compared to the agency's current appropriations.
Nearly $263.4m in additional funding compared to the previous fiscal year's total is allocated to the FDA in the House...